Get the Stockscreener App
8.04
1.11%
-0.09
Vir Biotechnology Inc Stock (VIR) Forecast
The Vir Biotechnology Inc (VIR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $41.52, representing a +416.42% increase from the current price of $8.04. The highest analyst price target is $70.98, and the lowest is $12.06.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VIR Price Target
Average 41.52
(+416.42% Upside)
Is Vir Biotechnology Inc (VIR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 27.49 | Buy |
| STOCH(9,6) | 12.66 | Buy |
| STOCHRSI(14) | 25.00 | Neutral |
| MACD(12,26) | -0.5862 | Sell |
| ADX(14) | 28.61 | Sell |
| William %R | -86.74 | Buy |
| CCI(14) | -73.56 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.357
Sell
|
8.3808
Sell
|
| MA20 |
9.0115
Sell
|
8.8641
Sell
|
| MA50 |
9.9988
Sell
|
9.5095
Sell
|
| MA100 |
9.8683
Sell
|
10.06
Sell
|
| MA200 |
10.69
Sell
|
12.61
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, VIR could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on VIR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 27.49 indicates that VIR is oversold. This indicates that VIR price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 12.66 indicates that VIR is oversold. This indicates that VIR price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 25 indicates that VIR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.61 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -73.56 indicates that VIR is still oversold but not to an extreme extent.
Long-term VIR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Vir Biotechnology Inc financial reports and earnings history, Vir Biotechnology Inc (VIR) stock could reach $26.54 by 2030, $33.65 by 2040 and $20.12 by 2050. See the projected annual prices until 2050 of the Vir Biotechnology Inc stock below:
- Vir Biotechnology Inc (VIR) is expected to reach an average price of $42.50 in 2035, with a high prediction of $72.27 and a low estimate of $23.80. This indicates an $428.63% rise from the last recorded price of $8.04.
- Vir Biotechnology Inc (VIR) stock is projected to chart a bullish course in 2040, with an average price target of $30.89, representing an $284.25% surge from its current level. The forecast ranges from a conservative $21.10 to a sky-high $33.65.
- Our analysts predict Vir Biotechnology Inc (VIR) to jump 317.46% by 2045, soaring from $16.54 to an average price of $33.56, potentially reaching $34.33. While $16.54 is the low estimate, the potential upside is significant.
- Vir Biotechnology Inc (VIR) stock is expected to climb by 2050, reaching an average of $11.56, a $43.79% jump from its current level. However, a wide range of estimates exists, with high and low targets of $20.12 and $9.0122, respectively, highlighting the market's uncertainty.
Vir Biotechnology Inc Stock (VIR) Year by Year Forecast
Vir Biotechnology Inc Stock (VIR) Price Forecast for 2024
Our forecast for VIR stock price in 2024 now indicates an average price target of $39.27 with a high forecast of $70.98 and a low forecast of $7.5592. The average prediction reflects an increase of +388.42% from the last recorded price of $8.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $42.48 | $12.06 | $70.98 | +428.33% |
| June, 2024 | $30.30 | $23.40 | $49.99 | +276.84% |
| July, 2024 | $28.63 | $23.13 | $35.89 | +256.12% |
| August, 2024 | $26.39 | $23.54 | $31.21 | +228.25% |
| September, 2024 | $37.53 | $26.06 | $38.45 | +366.74% |
| October, 2024 | $44.80 | $31.64 | $46.82 | +457.16% |
| November, 2024 | $48.14 | $41.39 | $50.32 | +498.70% |
| December, 2024 | $24.70 | $24.14 | $51.11 | +207.21% |
Vir Biotechnology Inc Stock (VIR) Price Forecast for 2025
Vir Biotechnology Inc Stock (VIR) is expected to reach an average price of $79.40 in 2025, with a high prediction of $137.25 and a low estimate of $21.54. This indicates an +887.51% rise from the last recorded price of $8.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $30.48 | $23.29 | $34.64 | +279.10% |
| February, 2025 | $30.88 | $29.04 | $40.14 | +284.07% |
| March, 2025 | $25.83 | $21.62 | $32.31 | +221.32% |
| April, 2025 | $26.85 | $24.54 | $30.32 | +234.00% |
| May, 2025 | $35.54 | $21.54 | $35.79 | +342.08% |
| June, 2025 | $72.84 | $33.98 | $137.25 | +805.94% |
| July, 2025 | $49.95 | $31.27 | $75.93 | +521.23% |
| August, 2025 | $39.43 | $38.83 | $52.10 | +390.38% |
| September, 2025 | $38.53 | $32.13 | $47.52 | +379.25% |
| October, 2025 | $41.87 | $37.39 | $44.63 | +420.78% |
| November, 2025 | $37.99 | $37.36 | $46.35 | +372.52% |
| December, 2025 | $34.79 | $31.00 | $38.47 | +332.65% |
Vir Biotechnology Inc Stock (VIR) Price Forecast for 2026
The predicted value for Vir Biotechnology Inc (VIR) in 2026 is set at an average of $34.66. Estimates vary from a peak of $54.50 to a trough of $14.82, indicating an +331.09% surge from the present price of $8.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $47.94 | $34.74 | $48.71 | +496.33% |
| February, 2026 | $40.24 | $38.76 | $51.02 | +400.55% |
| March, 2026 | $36.66 | $29.05 | $42.11 | +355.96% |
| April, 2026 | $29.22 | $26.72 | $37.85 | +263.41% |
| May, 2026 | $40.09 | $25.97 | $49.33 | +398.61% |
| June, 2026 | $35.21 | $28.71 | $54.50 | +337.97% |
| July, 2026 | $29.95 | $26.00 | $34.62 | +272.54% |
| August, 2026 | $19.76 | $19.71 | $31.51 | +145.73% |
| September, 2026 | $22.30 | $17.10 | $24.06 | +177.32% |
| October, 2026 | $18.06 | $17.90 | $22.99 | +124.58% |
| November, 2026 | $23.32 | $14.82 | $23.36 | +190.06% |
| December, 2026 | $21.17 | $18.34 | $23.45 | +163.31% |
Vir Biotechnology Inc Stock (VIR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Vir Biotechnology Inc (VIR) is $21.61, with a high forecast of $28.44 and a low forecast of $14.77. This indicates an +168.74% increase from the last price of $8.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $26.42 | $20.65 | $26.62 | +228.60% |
| February, 2027 | $26.85 | $23.80 | $28.44 | +233.95% |
| March, 2027 | $20.40 | $19.96 | $27.83 | +153.78% |
| April, 2027 | $16.00 | $14.77 | $20.39 | +99.05% |
| May, 2027 | $18.73 | $15.93 | $19.61 | +132.94% |
| June, 2027 | $24.00 | $18.33 | $25.04 | +198.48% |
| July, 2027 | $23.46 | $21.65 | $25.19 | +191.76% |
| August, 2027 | $24.40 | $21.34 | $24.44 | +203.51% |
| September, 2027 | $22.98 | $22.59 | $28.37 | +185.84% |
| October, 2027 | $19.69 | $18.86 | $26.01 | +144.91% |
| November, 2027 | $20.79 | $18.88 | $21.32 | +158.53% |
| December, 2027 | $21.40 | $20.14 | $23.03 | +166.11% |
Vir Biotechnology Inc Stock (VIR) Price Forecast for 2028
In 2028, Vir Biotechnology Inc (VIR) is projected to reach an average price of $13.94, with a high projection of $24.41 and a low estimate of $3.4685. This indicates an +73.37% rise from the last price of $8.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $24.21 | $20.32 | $24.28 | +201.12% |
| February, 2028 | $21.47 | $20.50 | $24.41 | +167.03% |
| March, 2028 | $11.10 | $9.5142 | $21.93 | +38.05% |
| April, 2028 | $9.2587 | $9.2187 | $11.24 | +15.16% |
| May, 2028 | $6.8232 | $6.7382 | $10.26 | -15.13% |
| June, 2028 | $5.3928 | $5.2328 | $6.8881 | -32.92% |
| July, 2028 | $5.8374 | $4.7625 | $6.3775 | -27.40% |
| August, 2028 | $6.757 | $5.5723 | $7.1823 | -15.96% |
| September, 2028 | $5.76 | $5.59 | $8.24 | -28.36% |
| October, 2028 | $5.6191 | $5.1408 | $7.9891 | -30.11% |
| November, 2028 | $4.4483 | $3.4685 | $5.7889 | -44.67% |
| December, 2028 | $4.4425 | $3.8775 | $5.9381 | -44.74% |
Vir Biotechnology Inc Stock (VIR) Price Forecast for 2029
The 2029 price forecast for Vir Biotechnology Inc Stock (VIR) is $35.42 on average, with a high prediction of $66.96 and a low estimate of $3.8774. This represents an +340.51% increase from the previous price of $8.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $18.55 | $3.8774 | $20.92 | +130.68% |
| February, 2029 | $38.46 | $8.036 | $66.96 | +378.31% |
| March, 2029 | $26.30 | $19.39 | $45.99 | +227.05% |
| April, 2029 | $24.65 | $19.13 | $31.90 | +206.64% |
| May, 2029 | $22.43 | $19.57 | $27.23 | +179.02% |
| June, 2029 | $26.34 | $22.11 | $34.49 | +227.64% |
| July, 2029 | $40.88 | $25.96 | $42.89 | +408.48% |
| August, 2029 | $44.24 | $37.49 | $46.41 | +450.26% |
| September, 2029 | $32.73 | $31.65 | $47.22 | +307.09% |
| October, 2029 | $26.63 | $19.42 | $32.49 | +231.21% |
| November, 2029 | $27.05 | $25.20 | $36.31 | +236.42% |
| December, 2029 | $22.03 | $17.81 | $28.49 | +173.97% |
Vir Biotechnology Inc Stock (VIR) Price Forecast for 2030
Vir Biotechnology Inc Stock (VIR) is expected to reach an average price of $75.63 in 2030, with a high forecast of $133.50 and a low forecast of $17.77. This signifies an +840.68% surge from the last price of $8.04.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $23.07 | $20.75 | $26.54 | +186.90% |
| February, 2030 | $31.78 | $17.77 | $32.03 | +295.22% |
| March, 2030 | $62.22 | $30.22 | $133.50 | +673.82% |
| April, 2030 | $46.22 | $27.53 | $76.01 | +474.93% |
| May, 2030 | $35.72 | $35.13 | $48.38 | +344.32% |
| June, 2030 | $35.60 | $32.27 | $43.83 | +342.82% |
| July, 2030 | $38.21 | $28.45 | $40.97 | +375.27% |
| August, 2030 | $34.35 | $33.72 | $42.70 | +327.25% |
| September, 2030 | $31.17 | $27.38 | $34.83 | +287.69% |
| October, 2030 | $44.35 | $31.13 | $45.12 | +451.61% |
| November, 2030 | $36.67 | $35.19 | $47.44 | +356.08% |
| December, 2030 | $33.11 | $25.49 | $38.54 | +311.79% |
3.69%
0.93%
Cap:
|
Volume (24h):